AbSci Corporation has completed the first milestone in its collaboration with AstraZeneca to develop an AI-designed antibody for cancer treatment, moving forward to the next phase of optimization.
AI Assistant
ABSCI CORP
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.